Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Kidney Diseases: full-pipeline trial registry
15 of 39 indexed Kidney Diseases trials are currently recruiting.
Corpus placement: #382 of 28,707 conditions by registered trial count.
39 US clinical trials · 15 currently recruiting · #382 of 28,707 conditions by registered trial count
Kidney Diseases: 39 US clinical trials tracked, 15 recruiting.
Kidney Diseases is the subject of 39 registered US clinical trials on ClinicalTrials.gov, 15 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is Northwestern University, running 2 of these trials.
Enrollment posture brief
Registry condition kidney-diseases
OPEN 15 | RECR 38% | LATE 6 | EARLY 7 | RANK #382 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Anaplastic Oligodendroglioma (38% recruiting · 13 trials)
Kidney Diseases lists 15 open slots (38% of 39 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Kidney Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Kidney Diseases recruits in line with its size-band peers.
15 of 39 indexed trials (38.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Kidney Diseases trials is spread across many organizations.
Northwestern University accounts for 2 of 39 trials (5.1%). 37 distinct sponsors appear on at least one study for this condition label.
-
Typical Kidney Diseases enrolment sits around 126 participants.
Median target enrolment is 126 among the 39 trials that report a genuine target (sentinel values excluded). 17 of those (43.6%) plan for fewer than 100 participants.
-
Kidney Diseases splits between interventional and observational designs.
26 interventional and 13 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
39 total, page 1 of 1
Rutgers University Study of the Genetics of Kidney Disease
Rutgers, The State University of New Jersey
NCT07217535
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
Wake Forest University Health Sciences
NCT03615235
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
The Rogosin Institute
NCT01802034
The Effects of the CF Carrier State on the Kidneys and Pancreas
Philip Polgreen
NCT05474417
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
Emory University
NCT06693661
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
University of California, San Francisco
NCT06798909
Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
Methodist Health System
NCT04182607
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Novartis Pharmaceuticals
NCT06858319
Transformative Research in Diabetic Nephropathy 2.0
University of Pennsylvania
NCT07444203
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
University of Illinois at Chicago
NCT06374537
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
Northwestern University
NCT05100017
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Wake Forest University Health Sciences
NCT04752293
Dietary Intervention to Improve Kidney Transplant Outcomes
University of California, Davis
NCT05449496
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Northwestern University
NCT05719714
Supporting VETerans With Kidney Disease Through Food As Medicine
VA Eastern Colorado Health Care System
NCT07194733
Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media
Johns Hopkins University
NCT03099434
BRINK (BRain In Kidney Disease) Memory Study 2.0
Anne Murray
NCT04975464
Access to Kidney Transplantation in Minority Populations
University of New Mexi
NCT04615819
Promoting Increases in Living Donation Via Tele-navigation (PILOT)
University of Alabama at Birmingham
NCT05468463
Long Term Extension Study in Patients With Primary Hyperoxaluria
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
NCT04042402
Savolitinib vs. Sunitinib in MET-driven PRCC.
AstraZeneca
NCT03091192
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
Sonavex
NCT04896476
Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19
University of Michigan
NCT04706533
Evaluation of the Analytical Performance of ALLEGRO™ Instrument
Nova Biomedical
NCT04096313
A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures
Children's Mercy Hospital Kansas City
NCT00142064
The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
Mayo Clinic
NCT00275535
Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring
MediBeacon
NCT05777174
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID)
NCT02741323
Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease
Shire
NCT00234702
Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease
Northwell Health
NCT03383627
BVA-200 vs BVA-100 Validation Study
Daxor Corporation
NCT06227819
Measurement of Renal Functional Reserve
Brigham and Women's Hospital
NCT03190070
Intermittent Pneumatic Compression Device for Vein Dilation in Kidney Disease Patients to Enable AVF Creation (FACT)
University of Chicago
NCT04063787
A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin
Cumberland Pharmaceuticals
NCT01238796
First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes
Goldfinch Bio
NCT04880291
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™
FAST BioMedical
NCT03095391
Effect of Hormone Therapy on Renal Function
University of Colorado, Denver
NCT04482920
Standard vs Mini-PCNL for the Treatment of Stone Disease
The Cleveland Clinic
NCT04069013
A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction
National Cancer Institute (NCI)
NCT00001298
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 3 |
| Phase 3 | 5 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Kidney Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Kidney Diseases trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Kidney Diseases page
39 registered trials, 15 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 15 Kidney Diseases trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Northwestern University sponsors the most Kidney Diseases trials on record, review their full trial history before evaluating a specific study. See Northwestern University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Kidney Diseases condition card totals 39 registered trials; most-linked intervention Placebo; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.